Get notified when AEMD files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (unchanged) — Management continues to express substantial doubt about the company's ability to continue as a going concern.
- Delisting (new) — Stock price below Nasdaq's $1.00 minimum bid price, risking delisting.
Aethlon Medical slashes offering price to $0.85, adds Nasdaq delisting risk
Filed July 1, 2026 · Compared to S-1 Jun 22, 2026 · ~1 min read
Key Changes
-
high
Offering price cut from $2.00 to $0.85 per share, reducing capital raised and increasing dilution for existing holders.
Dilution verify on EDGAR → -
high
New risk: stock trades below Nasdaq's $1.00 minimum bid price, risking delisting.
Risk Factors verify on EDGAR → -
high
Common warrants now require stockholder approval before exercise; special meeting required by Oct 1, 2026.
Offering verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.
Partner
Trade AEMD commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 30, 2026 · How we verify